Opko
In Brief This Week: FIND, Sophia Genetics, Dante Labs, BioReference Laboratories, and More
News items for the in vitro diagnostics industry for the week of July 26, 2021.
Increased Testing Revenues Boost Opko Health Q2 Revenues 47 Percent
The firm saw increases in SARS-CoV-2, clinical, and genomic testing and processed approximately 2.8 million COVID-19 PCR tests.
In Brief This Week: PerkinElmer, Qiagen, BioReference Laboratories, AstraZeneca, and More
News items for the in vitro diagnostics industry for the week of April 26, 2021.
Opko Health Q1 Revenues More Than Double Due to COVID-19 Test Demand
The company reported revenues of $545.2 million compared to $211.5 million in the year-ago quarter, primarily driven by COVID-19 testing.
BioReference Labs Inks Deal to Provide Rapid PCR, Point-of-Care COVID-19 Testing for MLB
The firm is using Mesa Biotech's Accula system for the testing, beginning Thursday, the start of the 2021 MLB season.
Oct 30, 2020
Opko Health Q3 Revenues Up 87 Percent
May 6, 2020
Opko Health Q1 Revenues Down 5 Percent
Feb 26, 2020